<DOC>
	<DOCNO>NCT02068599</DOCNO>
	<brief_summary>The primary purpose study evaluate change baseline 4 week topical administration TV-45070 ( 4 % 8 % ointment ) compare placebo relief symptom primary OA affect single knee</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy Topically Applied TV-45070 Ointment ) Participants With Primary Osteoarthritis ( OA ) Affecting Single Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Patient 40 85 year age , Patient primary OA single knee ( target knee ) confirm American College Rheumatology criterion . For patient take nonsteroidal antiinflammatory drug ( NSAIDs ) analgesic time screen visit , Patient visual analog scale ( VAS ) pain score acceptable range determine investigator screen Except OA , patient judge investigator medically healthy able participate study . Other criterion apply , please contact investigator additional information Patient secondary inflammatory arthritis knee psoriasis , rheumatoid arthritis ( RA ) , gout , primary bone disease , acute trauma . Patient symptomatic chondrocalcinosis Patient history fibromyalgia . Patient painful disable condition opinion investigator may confound assessment pain scoring . Patient uncontrolled cardiac , renal , hepatic systemic disorder opinion investigator may jeopardize patient . Patient significant edema skin disorder ( include sore , rash , ulcer ) target knee surround area . Patient history total partial knee replacement either leg . Patient major reconstructive knee surgery arthroscopy target knee within 6 month screen visit . Patient unable unwilling discontinue opioid and/or prescription analgesic control OA pain . Patient intolerant study drug , excipients , and/or acetaminophen . Patient us counter oral medication glucosamine chondroitin sulfate product , unless patient receive medication â‰¥3 month time screen visit maintains medication stable therapy duration study . Other criterion apply , please contact investigator additional information</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>OA</keyword>
	<keyword>Arthritis pain</keyword>
</DOC>